SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : INFE ... Infocall another Sleeper -- Ignore unavailable to you. Want to Upgrade?


To: omegaman who wrote (4493)6/9/1998 7:35:00 PM
From: omegaman  Read Replies (1) | Respond to of 10343
 
In comparing numbers:

for ACCUSTAFF, VINCAM AND ADMINISTAFF (INFE competitors, as stated by Tom Richfield)

By the way, for what its worth, these 3 companies between them have 1 hold Recommendation, 6 Moderate buys and 17 Strong Buys. Just some industry comparisons.

Accustaff has a market cap of 4B. Lets forget about them for comparisons sake.

VINCAN (VCAM)

PPS 21.00
P/E 41
P/S .3
Mkt Cap 327M
Sales 987M
EPS .39 (97)
EPS .64 (98 Est)
EPS growth 98/97 64.7
13M out

ADMINISTAFF (ASF)
PPS 40.75
P/E 75.5
P/S .4
Mkt Cap 590MM
Sales 1.3B
EPS .60 (97)
EPS ..73 (98 Est)
EPS growth 98/97 21.0
13.9M out

Industry P/E 26, EPS growth 22.8

Tom said he was shooting for 100M in revs. .3 X Sales 30M Market Cap would be justified and conservative at these levels(BB Stock withstanding). @ 6 M issued shares( I think thats what I read) thats 5.00. Now its a growth game beyond that. IMHO

Good luck

O-man